Lifevantage Corp
LFVN Nasdaq· Pharmaceutical Preparations
Last close · Oct 27, 2026
$5.93
KIRA · Stoqly’s AI analyst, in plain words
- Lifevantage Corp had $183M of revenue in fiscal 2026, down 20.1% on the year before. Over five years, revenue changed −3.7% a year on average.
- Its operating margin was 3.3%, down 2.0 pts: of every 100 in sales, about 3 is left after running the business.
- Lifevantage Corp made $5.1M of net profit in fiscal 2026. From fiscal 2017 to 2026, diluted EPS grew 15.4% a year.
- Free cash flow was $6.7M in fiscal 2026, 3.7% of revenue.
- Lifevantage Corp returned $4.4M to shareholders in fiscal 2026, 66% of free cash flow. The diluted share count fell 2.2%.
Market cap
$75.3M
P/E
14.8x
Revenue
$183M
Net income
$5.1M
Free cash flow
$6.7M
Operating margin
3.3%
Lifevantage Corp in 30 seconds · fiscal 2026
Are sales growing?
−20.1%
No. Sales fell 20.1% last year.
Does it make a profit?
2.8%
A little. It keeps 2.8% of every sale as profit.
Does profit turn into cash?
3.7%
Partly. 3.7% of sales ends up as free cash.
How healthy are the accounts?
5 / 8
Mixed. It passes 5 of 8 health tests.
How is the share priced?
14.8x
One share costs 14.8 times its yearly profit per share.
What Lifevantage Corp does
No business description yet.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K · Aug 27, 2026
- Legal name
- Lifevantage Corp
- CIK
- 0000849146
Lifevantage Corp · LFVN
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $206M | $213M | $200M | $229M | $183M |
| Revenue growth | −6.3% | 3.4% | −6.2% | 14.2% | −20.1% |
| Gross margin | 81.5% | 79.7% | 79.3% | 80.4% | 77.6% |
| Operating margin | 3.7% | 2.0% | 2.2% | 5.3% | 3.3% |
| Net income | $3.1M | $2.5M | $2.9M | $9.8M | $5.1M |
| Net margin | 1.5% | 1.2% | 1.5% | 4.3% | 2.8% |
| Diluted EPS | $0.24 | $0.20 | $0.23 | $0.75 | $0.40 |
| Cash | |||||
| Cash from operations | $8.0M | $6.8M | $12.2M | $11.9M | $10.2M |
| Capital expenditure | $1.5M | $3.1M | $2.2M | $1.4M | $3.6M |
| Free cash flow | $6.4M | $3.8M | $10.0M | $10.5M | $6.7M |
| FCF margin | 3.1% | 1.8% | 5.0% | 4.6% | 3.7% |
| Dividends paid | $0.4M | $1.6M | $6.9M | $2.1M | $2.3M |
| Share buybacks | $8.8M | $0.8M | $6.4M | $3.1M | $2.0M |
| Share count change | −8.4% | −3.8% | 3.3% | 0.0% | −2.2% |
| Debt and strength | |||||
| Cash and short-term investments | $20.2M | $21.6M | $16.9M | $20.2M | $14.9M |
| Shareholders' equity | $31.5M | $34.6M | $26.0M | $34.6M | $33.6M |
| Current ratio | 1.8x | 2.3x | 1.7x | 1.9x | 1.9x |
| Interest coverage | 757.5x | — | — | — | — |
| Returns and quality | |||||
| Return on equity | 9.1% | 7.7% | 9.7% | 32.3% | 14.9% |
| Return on tangible equity | 10.1% | 7.4% | 11.4% | 28.5% | 16.9% |
| Piotroski F-score | 5 | 6 | 5 | 6 | 5 |
| Altman Z'' | −1.0 | −0.8 | −2.9 | −0.4 | −1.6 |
Insiders bought, 12 months
$0.2M
2 insiders
Insiders sold, 12 months
$0.5M
2 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Lifevantage Corp · LFVN
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $5.93 a share, the company is worth $75.3M: 14.8 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0000849146). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.